 Sensory visual testing idiopathic intracranial hypertension measures Management decisions idiopathic intracranial hypertension IIH pseudotumor cerebri presence change visual loss change tests sensory visual function time results right eye patients clinical status decrease papilledema grade outcome measures initial final examinations Contrast sensitivity significant improvement middle high spatial frequency targets Snellen acuity color tests period Goldmann visual field grade initial final visit presence defect confrontation visual fields Numerical analyses automated perimetry thresholds significant improvement Generalized loss nasal side visual field present initial examination improvement central inferior paracentral areas Patients IIH contrast sensitivity perimetry disease-specific strategy